| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 382.46B | 389.08B | 325.86B | 336.49B | 249.14B | 240.08B |
| Gross Profit | 100.49B | 92.70B | 80.57B | 89.25B | 45.38B | 31.21B |
| EBITDA | 118.01B | 111.92B | 82.89B | 76.34B | 37.53B | 26.79B |
| Net Income | 85.38B | 81.15B | 53.66B | 67.39B | -30.99B | -2.73B |
Balance Sheet | ||||||
| Total Assets | 677.63B | 681.60B | 660.93B | 568.18B | 471.94B | 624.79B |
| Cash, Cash Equivalents and Short-Term Investments | 153.34B | 152.35B | 173.00B | 194.96B | 150.27B | 165.40B |
| Total Debt | 7.63B | 1.48B | 1.84B | 2.20B | 2.59B | 114.33B |
| Total Liabilities | 124.59B | 124.34B | 123.35B | 111.01B | 69.17B | 190.29B |
| Stockholders Equity | 523.64B | 527.75B | 503.90B | 425.63B | 371.64B | 400.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 51.08B | 34.89B | 77.85B | 1.86B | 35.56B |
| Operating Cash Flow | 0.00 | 141.61B | 100.81B | 113.82B | 18.14B | 50.71B |
| Investing Cash Flow | 0.00 | -120.57B | -110.37B | -61.97B | 32.20B | -16.81B |
| Financing Cash Flow | 0.00 | -36.02B | -28.14B | -14.50B | -70.27B | -12.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥643.76B | 7.90 | 8.62% | 2.95% | 4.14% | 91.38% | |
78 Outperform | ¥5.36T | 9.45 | 8.54% | 2.91% | -11.79% | 18.12% | |
73 Outperform | ¥739.98B | 15.20 | ― | 3.93% | 2.57% | -4.79% | |
68 Neutral | ¥2.14T | 21.95 | 2.23% | 3.07% | -7.68% | -73.03% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
62 Neutral | ¥1.02T | 2,361.65 | 24.31% | 0.73% | 10.13% | 25.50% | |
56 Neutral | ¥3.97T | 11.54 | -0.15% | 2.74% | -14.13% | 33.18% |